About Pricing FAQs Providers Trials Blog

Login Get started

Finding studies

Your health journey, clearly organized.

Questions? feedback@clareohealth.com

Product

How it works
Pricing
For Providers
Trials

Company

About
Blog
FAQ

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

Long-term Follow-up Gene Therapy Study for RPGR- XLRP

NCT04312672·5 sites·ClinicalTrials.gov

What this study is about

Take this into the appointment.

Saves the questions and what to expect into your notes, next to the visit they belong to.

Keep this study

Lead

MeiraGTx Ocular UK Ltd

Age

5–any

Sex

MALE

Healthy volunteers

Not accepted

You may be eligible if

Received AAV5-hRKp.RPGR in the MGT009 Study

You may not be if

Unwilling or unable to meet with the requirements of the study

The record

StatusCompleted

PhaseNo phase

Taking part42

StartedJul 2017

UpdatedSep 25, 2026

Conditions

X-Linked Retinitis Pigmentosa

Where5

Massachusetts Eye and Ear Infirmary
Boston, Massachusetts, United States
Univ of Michigan Medical Center
Ann Arbor, Michigan, United States
University of Pittsburgh Medical Center
Pittsburgh, Pennsylvania, United States

Clareo Health | Long-term Follow-up Gene Therapy Study for RPGR- XLRP